Legal Representation
Attorney
Kevin G. Rooney
USPTO Deadlines
Next Deadline
40 days remaining
Non-Final Action E-Mailed
Due Date
February 12, 2026
Extension Available
Until May 12, 2026
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 12, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 12, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 5, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Biological fluid biopsy devices, namely, vitreous fluid biopsy devices; biorepositories, namely, facilities for collecting, preserving and/or distributing biological samples.
Class 044
Analysis of ocular fluid, namely, molecular analysis of vitreous and/or aqueous fluid; Sales and/or licensing of medical data, namely, sales and/or licensing of ocular data for pharmaceutical and/or drug development; sales and/or licensing of biologic specimens, namely, sales and/or licensing of ocular biological specimens for pharmaceutical and/or drug development; therapeutic analysis, namely, analysis for identifying therapeutic targets; oculomic integrated AI analysis for biomarker identification.
Additional Information
Pseudo Mark
OCULAR DIAGNOSIS
Classification
International Classes
010
044